NeoPred: dual-phase CT AI forecasts pathologic response to neoadjuvant chemo-immunotherapy in NSCLC
Background Accurate preoperative prediction of major pathological response or pathological complete response after neoadjuvant chemo-immunotherapy remains a critical unmet need in resectable non-small-cell lung cancer (NSCLC). Conventional size-based imaging criteria offer limited reliability, while...
| الحاوية / القاعدة: | Journal for ImmunoTherapy of Cancer |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
BMJ Publishing Group
2025-05-01
|
| الوصول للمادة أونلاين: | https://jitc.bmj.com/content/13/5/e011773.full |
